OBREDON

Peak

guaifenesin; hydrocodone bitartrate

NDAORALSOLUTION
Approved
Nov 2014
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Nov 13, 2035
117 months away
Patent Expiry
Nov 13, 2035

Patent Records (3)

Patent #ExpiryTypeUse Code
10105324
Nov 13, 2035
SubstanceProduct
U-2023
9549907
Nov 13, 2035
SubstanceProduct
U-2023
9808431
Nov 13, 2035
SubstanceProduct
U-2023
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers